Monthly Newsletter

Drawing upon a wealth of experience of working with a wide range of 3D cell culture procedures and formats - AMSBIO has produced an extensive 48-page handbook for research scientists looking to culture cells in more physiologically relevant environments.

Over the past two decades, many researchers have actively sought ways to culture cells in 3D. The conclusion reached by many researchers is that there is no single optimal solution, each cell type needs a different environment and many biological processes may need specific methods to study them.

Leading the field in the provision of solutions for 3D Cell Culture, AMSBIO’s scientists have distilled the best technologies into a useful guide. Covering everything from innovative 384-well scaffold-based screening through the incorporation of natural ECMs or biomimetics; this handbook is a valuable resource not just for cancer research but also for neuroscience, drug discovery and regenerative medicine applications. An easy-to-use troubleshooting table is included to help researchers obtain the optimal 3D cell culture matrix for different applications. 

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and development in the medical, nutrition, cosmetics and energy industries. The AMSBIO range includes specialist antibodies, peptides and recombinant proteins. In addition the company is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as experts in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance screening outcomes and eventual prognosis. With a range of molecular detection reagents, and a significant Biorepository the company can also provide tissue DNA, RNA, protein and microarray products. Key research areas for these products include: Oncology, Regenerative Medicine, Environmental Analysis, Cytotoxicity Screening, Glycomics and Stem Cell Biology.

more about amsbio

more news from amsbio